|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-2-17
|
|
pubmed:abstractText |
There is an urgent need for markers that can predict the efficacy of adjuvant chemotherapy in patients with solid tumors. This study was designed to evaluate whether monitoring of micrometastases in bone marrow can predict the response to systemic chemotherapy in breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
80-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10623696-Analysis of Variance,
pubmed-meshheading:10623696-Antineoplastic Agents,
pubmed-meshheading:10623696-Bone Marrow,
pubmed-meshheading:10623696-Breast Neoplasms,
pubmed-meshheading:10623696-Chemotherapy, Adjuvant,
pubmed-meshheading:10623696-Female,
pubmed-meshheading:10623696-Follow-Up Studies,
pubmed-meshheading:10623696-Germany,
pubmed-meshheading:10623696-Humans,
pubmed-meshheading:10623696-Immunohistochemistry,
pubmed-meshheading:10623696-Keratins,
pubmed-meshheading:10623696-Middle Aged,
pubmed-meshheading:10623696-Multivariate Analysis,
pubmed-meshheading:10623696-Neoplasm, Residual,
pubmed-meshheading:10623696-Neoplasm Metastasis,
pubmed-meshheading:10623696-Prognosis,
pubmed-meshheading:10623696-Regression Analysis,
pubmed-meshheading:10623696-Survival Rate
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
|
|
pubmed:affiliation |
I. Frauenklinik der Ludwig-Maximilians-Universität, Munich, Germany. Sbraun@fk-i.med.uni-muenchen.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
